InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: hschlauch post# 41144

Tuesday, 11/07/2017 2:34:07 PM

Tuesday, November 07, 2017 2:34:07 PM

Post# of 48316
The mention of personalized tumor vaccines did catch my eye. Merck is heavily involved in vaccines and would be very interested in this. The mention of vaccines had me thinking about Inovio. They are involved in vaccines and electroporation. I think in the future all 3 of these companies will be more linked together in some way. I think Oncosec still has a tie to Invoio regarding licensing fees for commercialized products.

Just speculation on my part but if Oncosec owed royalties to Inovio for any commercialized products using electroporation it might be in their best interest in pursuing a sale of the company after an FDA approval for immunopulse. I hope that is what happens. Inovio can get royalty money from Merck instead.